| APA |
Ada, G., Yalçın, C., Orhan, B., Pınar, İ. E., Ersal, T., Ozkocaman, V., Özkalemkaş, F., & Ali, R. (2021). HIV Related Primary Central Nervous System Lymphoma: Case Study. Turkish Journal of Internal Medicine, 3(Supplement 1), 77-78. https://doi.org/10.46310/tjim.876945
|
|
| AMA |
1.Ada G, Yalçın C, Orhan B, et al. HIV Related Primary Central Nervous System Lymphoma: Case Study. Turk J Int Med. 2021;3(Supplement 1):77-78. doi:10.46310/tjim.876945
|
|
| Chicago |
Ada, Gül, Cumali Yalçın, Bedrettin Orhan, et al. 2021. “HIV Related Primary Central Nervous System Lymphoma: Case Study”. Turkish Journal of Internal Medicine 3 (Supplement 1): 77-78. https://doi.org/10.46310/tjim.876945.
|
|
| EndNote |
Ada G, Yalçın C, Orhan B, Pınar İE, Ersal T, Ozkocaman V, Özkalemkaş F, Ali R (March 1, 2021) HIV Related Primary Central Nervous System Lymphoma: Case Study. Turkish Journal of Internal Medicine 3 Supplement 1 77–78.
|
|
| IEEE |
[1]G. Ada et al., “HIV Related Primary Central Nervous System Lymphoma: Case Study”, Turk J Int Med, vol. 3, no. Supplement 1, pp. 77–78, Mar. 2021, doi: 10.46310/tjim.876945.
|
|
| ISNAD |
Ada, Gül - Yalçın, Cumali - Orhan, Bedrettin - Pınar, İbrahim Ethem - Ersal, Tuba - Ozkocaman, Vildan - Özkalemkaş, Fahir - Ali, Rıdvan. “HIV Related Primary Central Nervous System Lymphoma: Case Study”. Turkish Journal of Internal Medicine 3/Supplement 1 (March 1, 2021): 77-78. https://doi.org/10.46310/tjim.876945.
|
|
| JAMA |
1.Ada G, Yalçın C, Orhan B, Pınar İE, Ersal T, Ozkocaman V, Özkalemkaş F, Ali R. HIV Related Primary Central Nervous System Lymphoma: Case Study. Turk J Int Med. 2021;3:77–78.
|
|
| MLA |
Ada, Gül, et al. “HIV Related Primary Central Nervous System Lymphoma: Case Study”. Turkish Journal of Internal Medicine, vol. 3, no. Supplement 1, Mar. 2021, pp. 77-78, doi:10.46310/tjim.876945.
|
|
| Vancouver |
1.Gül Ada, Cumali Yalçın, Bedrettin Orhan, İbrahim Ethem Pınar, Tuba Ersal, Vildan Ozkocaman, Fahir Özkalemkaş, Rıdvan Ali. HIV Related Primary Central Nervous System Lymphoma: Case Study. Turk J Int Med. 2021 Mar. 1;3(Supplement 1):77-8. doi:10.46310/tjim.876945
|
|